| Market Cap | ₹3,981Cr |
| ROE | 20.12% |
| P/E Ratio(TTM) | 18.48 |
| EPS(TTM) | 130.25 |
| P/B Ratio | 7.19 |
| Dividend Yield | 1.00% |
| Industry P/E | 40.62 |
| Book Value | 334.94 |
| Debt to Equity | 0.00 |
| Face Value | 8 |
| Parent Organisation | RPG Life Sciences Limited |
| Managing Director | Mr. Yugal Sikri |
| NSE Symbol | RPGLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |